Guangzhou Sinogen Pharmaceutical was selected in the 2022 China Bio-pharmaceutical Industry Chain Innovation List.
The "2022 China Bio-pharmaceutical Industry Chain Innovation List" was officially released at the opening ceremony of the "Second China Bio-pharmaceutical Industry Chain Innovation and Transformation Summit Forum" on December 30. Sinogen Pharmaceutical won the Kunpeng Award (the most promising start-up) and the Golden Horse Award (the most promising key technology platform).
Introduction to the 2022 China Biomedical Industry Chain Innovation List
From May to early June of 2022, the evaluation model and candidate list was prepared. From July to August, the promotion and quantitative ranking of the list was launched. From August to early September, the online expert review and public online voting of various awards was conducted. Among them, the number of public online voting participants exceeded 35,000 and the total number of votes exceeded 100,000.
Through the weighted calculation of the selection index, in order to make the spring of innovation fully flow, the China Bio-Pharmaceutical Industry Chain Innovation and Transformation Alliance, Nanjing Bio-Pharmaceutical Industry Innovation and Transformation Center, Yaodu, Yaokahui, the Editorial Board of “Pharmaceutical Progress” and Industrial Securities, with the purpose of "setting industry benchmarks, stimulating innovation potential and planting innovation soil", face the world's leading edge of science and technology and gather national strategic needs, jointly launched the "2022 China Bio-pharmaceutical Industry Chain Innovation List".
Under the guidance of the national major project of "major new drug development", from 12 dimensions, such as target novelty, technological progressiveness, clinical demand and R&D investment, a scoring standard is set. The academician expert group conducts video discussion, online voting and weighted comprehensive evaluation, and finally selects the Benchmark award, Kunpeng Award and Golden Horse Award, which has become the trend in the field of innovation and transformation of the biomedical industry.
